SCHEMBL7542452

SCHEMBL7542452

Nc1cccnc1OCc1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGMT P16455 1/20 0.49
SYK P43405 3/20 0.49
PARP10 Q53GL7 1/20 0.46
GABRA1 P14867 6/20 0.46
GABRG2 P18507 6/20 0.46
GABRB3 P28472 6/20 0.46
GABRA5 P31644 6/20 0.46
GABRA3 P34903 6/20 0.46
GABRA2 P47869 6/20 0.46
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TLR8 Q9NR97 1/20 0.45
TLR7 Q9NYK1 1/20 0.45
AURKB Q96GD4 1/20 0.44
INCENP Q9NQS7 1/20 0.44
HRH1 P35367 1/20 0.44
ABCB1 P08183 1/20 0.43
HTR1A P08908 1/20 0.43
DRD2 P14416 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9719784 0.80 SYK (0.58) SYKPARP10KDM4EALDH1A1SMN1; SMN2
SCHEMBL1936855 0.80 LTA4H (0.59) MGMTALDH1A1SMN1; SMN2L3MBTL1
Hydrochloric Acid SCHEMBL27163847 0.79 LTA4H (0.57) MGMTSMN1; SMN2L3MBTL1
SCHEMBL30418203 0.79 KDM4E (0.45) MGMTSYKPARP10GABRA1GABRG2
SCHEMBL28696981 0.77 KMT2A (0.39) KDM4EALDH1A1
SCHEMBL9117255 0.75 LTA4H (0.67) MGMTSYKPARP10KDM4EALDH1A1
SCHEMBL1647418 0.73 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL29977462 0.73 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL31700841 0.73 NOS3 (0.34) KDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL30361386 0.73 PARP10 (0.64) SYKPARP10KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020035134-A1 Indoline derivatives useful as 5-HT-2C receptor antagonists SMITHKLINE BEECHAM P.L.C. 2002-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035134-A1 Indoline derivatives useful as 5-HT-2C receptor antagonists HTR2C, HTR1A, HTR1D MGMT 1854/4885SYK 1978/4885PARP10 3054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.